GLAXOSMITHKLINE PLC

Average Profitability
<0.0001%
Insider Buys Quantity
20
Insider Buys Sum
$639.56M
Insider Sells Quantity
11
Insider Sells Sum
$3.02B

Insider Activity of GLAXOSMITHKLINE PLC

According to the SEC Form 4 filings, GLAXOSMITHKLINE PLC, being in a position of

  1. 10 percent owner at Wave Life Sciences Ltd.,
    оver the last 12 months, has bought 6091930 shares for $38.84M, and sold 0 shares,
    over all time since 2023-12-07, has bought 6091930 shares for $38.84M, and sold 0 shares.

The largest purchase of all time was on 2010-11-29 and amounted to 11500000 shares of Innoviva, Inc. for $258.75M.

The largest sale of all time was on 2011-01-31 and amounted to 30755151 share of Quest Diagnostics Incorporated for $1.69B.

Biography of GLAXOSMITHKLINE PLC

No biography is available at this moment.

2024-09-27PurchaseWave Life Sciences Ltd.
WVE
10 percent owner
2.79M
2.2327%
$8.00$22.34M+5.31%
2023-12-07PurchaseWave Life Sciences Ltd.
WVE
10 percent owner
3.3M
3.4922%
$5.00$16.5M+20.21%
2021-07-02PurchaseCVRx, Inc.
CVRX
10 percent owner
550,000
1.932%
$18.00$9.9M-56.83%
2021-05-20SaleInnoviva, Inc.
INVA
10 percent owner
32.01M
33.288%
$12.25$392.06M+23.35%
2020-07-15SaleBicycle Therapeutics plc
BCYC
10 percent owner
6,294
0.0326%
$19.40$122,090+13.66%
2020-07-14SaleBicycle Therapeutics plc
BCYC
10 percent owner
3,194
0.0166%
$19.27$61,561+11.13%
2020-07-14PurchaseNkarta, Inc.
NKTX
1.67M
2.6861%
$18.00$30M-11.28%
2020-05-20SaleProgyny, Inc.
PGNY
10 percent owner
8M
9.469%
$25.75$206M+19.93%
2019-05-28PurchaseBicycle Therapeutics plc
BCYC
771,428
12.0507%
$14.00$10.8M-13.68%
2018-07-30PurchaseLiquidia Corporation
LQDA
Former 10% holder
148,818
1.2822%
$11.00$1.64M+38.27%
2018-07-17PurchaseSpero Therapeutics, Inc.
SPRO
10 percent owner
80,000
0.4892%
$12.50$1M-6.41%
2017-11-06PurchaseSpero Therapeutics, Inc.
SPRO
10 percent owner
428,571
5.3915%
$14.00$6M-3%
2016-10-24PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
133,000
1.0843%
$14.00$1.86M+31.44%
2014-10-27SaleAmicus Therapeutics, Inc.
FOLD
22.63M
28.0717%
$5.29$119.74M+86.13%
2013-11-20PurchaseAmicus Therapeutics, Inc.
FOLD
Former 10% Owner (1)
1.5M
2.1989%
$2.00$3M+29.25%
2012-08-03PurchaseInnoviva, Inc.
INVA
10 percent owner
316,334
0.4537%
$28.21$8.92M-8.32%
2012-07-17PurchaseAmicus Therapeutics, Inc.
FOLD
Former 10% Owner (1)
2.95M
6.3627%
$6.30$18.58M-38.62%
2012-05-16PurchaseInnoviva, Inc.
INVA
10 percent owner
10M
14.8687%
$21.29$212.89M+9.68%
2012-02-14PurchaseInnoviva, Inc.
INVA
10 percent owner
176,936
0.2829%
$18.12$3.21M+21.27%
2011-11-01PurchaseInnoviva, Inc.
INVA
10 percent owner
116,822
0.1996%
$22.23$2.6M+3.12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.